Decoy Therapeutics (DCOY) Payables (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Payables of $936030.0 for Q1 2026, down 40.87% year-over-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $940586.0 in Q4 2025.
Decoy Therapeutics (DCOY) Payables (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Payables for 13 consecutive years, with $936030.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 40.87% year-over-year to $936030.0; the TTM figure through Mar 2026 stood at $936030.0 (down 40.87% YoY), while the FY2025 annual figure was $940586.0, down 17.27% from the prior year.
- Payables steadied at $936030.0 in Q1 2026 per DCOY's latest filing, from $940586.0 in the prior quarter.
- Across five years, Payables topped out at $3.5 million in Q1 2023 and bottomed at $494650.0 in Q3 2024.
- Historically, Payables has averaged $1.5 million across 5 years, with a median of $1.5 million in 2025.
- Annual changes were most pronounced in 2024 — Payables tumbled 76.82% — and 2025, when it surged 130.46%.
- Decoy Therapeutics' Payables stood at $2.9 million in 2022, then sank by 68.41% to $902853.0 in 2023, then increased by 25.93% to $1.1 million in 2024, then slipped by 17.27% to $940586.0 in 2025, then dropped by 0.48% to $936030.0 in 2026.
- Business Quant data shows DCOY's Payables at $936030.0 in Q1 2026, $940586.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 35.57 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 936,030.00 |
| Dec 31, 2025 | 940,586.00 |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 494,650.00 |
| Jun 30, 2024 | 643,051.00 |
| Mar 31, 2024 | 813,957.00 |
| Dec 31, 2023 | 902,853.00 |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 1.23 Mn |